Tenofovir Disoproxil Fumarate (TDF) in HIV-1 Patients Who Have Never Taken Anti-HIV Drugs
Not Applicable
Completed
- Conditions
- HIV Infections
- Registration Number
- NCT00016588
- Lead Sponsor
- Gilead Sciences
- Brief Summary
The purpose of this study is to look at the effectiveness of tenofovir disoproxil fumarate (TDF) in HIV-infected patients who have never taken anti-HIV drugs.
- Detailed Description
Patients receive TDF.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Aaron Diamond AIDS Rsch Ctr / Rockefeller Univ
🇺🇸New York, New York, United States